| Literature DB >> 33009876 |
Yoon Ah Cho1, Yoon-La Choi1, Inwoo Hwang1, Kyungjong Lee2, Jong Ho Cho3, Joungho Han1.
Abstract
BACKGROUND: Nuclear protein in testis (NUT) carcinoma is a rare tumor associated with NUT rearrangement that can present as poorly differentiated to undifferentiated carcinoma, with or without abrupt squamous differentiation. It is often misdiagnosed as poorly differentiated carcinoma or undifferentiated carcinoma if NUT is not suspected. In this study, we retrospectively analyzed pulmonary NUT carcinoma cases diagnosed with NUT immunohistochemical staining and discuss the differential diagnosis to provide information for this rare and aggressive entity.Entities:
Keywords: Lung cancer; NUT carcinoma; pathology
Mesh:
Substances:
Year: 2020 PMID: 33009876 PMCID: PMC7606005 DOI: 10.1111/1759-7714.13648
Source DB: PubMed Journal: Thorac Cancer ISSN: 1759-7706 Impact factor: 3.500
Clinical characteristics of 10 nuclear protein in testis (NUT) cases
| Case No. | Age | Sex | Specimen | Organ | Smoking history (PY) | Clinical symptoms | Stage | Tumor location | Treatment | Follow‐up |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 34 | M | Biopsy | Lung | Ex‐smoker (7.5) | Right upper quadrant abdominal pain | IV | Peripheral | Genexol/carboplatin, radiation therapy, pembrolizumab | Transferred to another institute |
| 2 | 45 | M | Biopsy | Lymph node | Non‐smoker | Incidental (routine check‐up) | IIIA | Central | Alimta/carboplatin, pembrolizumab | Complete response |
| 3 | 32 | M | Biopsy | Liver | Ex‐smoker (6) | Chest pain, cough | IV | Central | Refused further treatment | Increased liver function test, transferred to another institute |
| 4 | 38 | M | Biopsy | Lymph node | Non‐smoker | Incidental (Routine check‐up) | IIIA | Central | Palliative gemcitabine/ cisplatin, pneumonectomy, adjuvant navelbine/cisplatin | Complete response |
| 5 | 49 | M | Mass excision | Pleura | Non‐smoker | Chest pain | IV | Peripheral | Palliative vincristine, doxorubicin, tripegfilgrastim and radiation | Disease progression, transferred to another institute |
| 6 | 41 | F | Biopsy | Pleura | Non‐smoker | Flank pain | IV | Peripheral | s/p palliative gemcitabine/cisplatin | Partial response |
| 7 | 44 | M | Resection | Lung | Ex‐smoker (10) | Incidental (routine check‐up) | IIIA | Peripheral | Lobectomy, adjuvant Paclitaxel/carboplatin | Gamma knife surgery for brain metastasis |
| 8 | 48 | F | Resection | Lung | Non‐smoker | Cough (routine check‐up) | IIIA | Central | Neoadjuvant carboplatin, genexol, pembrolizumab, lobectomy, adjuvant pembolizumab | Complete response |
| 9 | 43 | M | Biopsy | Lung | Current smoker (20) | Incidental | IA | Peripheral | Lobectomy with adjuvant paclitaxel/carboplatin | Complete response |
| 10 | 18 | F | Biopsy | Lung | Non‐smoker | Chest pain | IV | Central | Palliative paclitaxel with carboplatin | Stable disease |
PY, pack‐year; s/p, status post.
Pathological characteristics of 10 nuclear protein in testis (NUT) cases
| Case No. | Initial diagnosis | Final diagnosis | Morphology | Necrosis | Fibrotic stroma | Keratini‐zation | Inflamm‐atory cells | Other IHC results | PD‐L1 IHC TPS (%) | ALK IHC | ROS‐1 IHC | EGFR status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Spindle cell neoplasm | Atypical cell proliferation, suggestive of NUT carcinoma | Spindle | N | N | N | N | NUT, p63, TTF‐1, CD34, STAT6: + | 80 | — | — | Wild type |
| 2 | Metastatic NUT‐midline carcinoma | Metastatic NUT‐midline carcinoma | Round, squamoid | Y | N | N | Y (neutrophil) |
NUT, CK (AE1/AE3), p63: + TTF‐1, CD56, chromogranin, CD99, CD45: − | 70 | — | — | N/A |
| 3 | Squamous cell carcinoma | Poorly differentiated carcinoma, favor NUT carcinoma | Squamoid | Y | N | N | Y (neutrophil) |
NUT, p63:+ TTF‐1: − | 1 | — | — | Wild type |
| 4 | Metastatic squamous cell carcinoma from lung | NUT carcinoma, squamous cell type with pseudoglandular pattern | Squamoid | Y | Y | N | N |
NUT, p63:+ TTF‐1: − | 0 | — | — | Wild type |
| 5 | Undifferentiated round cell sarcoma, FNCLCC grade 3/3 | NUT carcinoma | Round | N | Y | N | N |
NUT, p53: + Bcl‐2: Focal + CK (AE1/AE3): Weak + p63, CD56, Desmin,Pan TRK, S‐100, Actin (Smooth muscle): − | 0 | — | — | Wild type |
| 6 | Metastatic Squamous cell carcinoma | Suggestive of NUT carcinoma | Squamoid | Y (focal) | Y | N | Y (lymphocyte) | NUT: + | 0 | — | — | Wild type |
| 7 | Poorly differentiated, non‐small cell carcinoma, consistent with NUT carcinoma | Poorly differentiated, non‐small cell carcinoma, consistent with NUT carcinoma | Round | Y | Y | N | Y (lymphocyte) |
NUT:+ p63, CD56:− | 0 | — | — | Wild type |
| 8 | Metastatic squamous cell carcinoma | NUT carcinoma, squamous cell type | Squamoid | N | N | N | Y (lymphocyte) |
NUT, p63:+ CD56:− | 0 | — | — | Wild type |
| 9 | Consistent with NUT carcinoma | Consistent with NUT carcinoma | Spindle, squamoid | N | N | N | Y (lymphocyte) | NUT, p63:+ | 0 | — | — | N/A |
| 10 | NUT carcinoma, undifferentiated carcinoma component | NUT carcinoma, undifferentiated carcinoma component | Spindle, round | N | N | N | N |
NUT, p63:+ TTF‐1, CD56:− | 0 | — | — | N/A |
−, negative staining; +, positive staining; ALK, anaplastic lymphoma kinase; CK, cytokeratin; EGFR, epidermal growth factor receptor; FNCLCC, Fédération Nationale des Centres de Lutte le Cancer; N, Absent; N/A, not available; TPS, tumor proportion score; Y, present.
Figure 1Histological features of representative nuclear protein in testis (NUT) carcinoma. (a, b) NUT carcinoma consists of spindle cells that can be misdiagnosed as spindle cell neoplasm (Case 1). (c) The tumor shows abrupt transition to a squamoid component intermingled with undifferentiated features (Case 2); and (d) may show necrosis (Case 3). (e) Tumors might be separated with fibrous stroma (Case 4). (f–h) The undifferentiated round cells without cytoplasm can mimic round cell sarcoma (Case 5). (i, j) There might be mitotic and pleomorphic features (Case 7); and (k, l) small round tumors with suspicious nuclear molding and inconspicuous nucleoli for neuroendocrine tumors (Case 10).
Figure 2Immunohistochemical staining of representative nuclear protein in testis (NUT) carcinoma. Case 1 shows positive staining for (a) cytokeratin (AE1/AE3): (b) NUT: and (c) STAT6. Case 3 shows positive staining for (d) NUT; and (e) p63. (f) NUT; and (g) p63 can be positive, as in Case 4. Diffuse NUT staining is shown for (h) Case 5; and (i) Case 7. (k) Case 5 and Case 7 showed NUT translocation confirmed by fluorescence in situ hybridization. Case 10 showed positive (j) NUT; and negative staining for (l) CD56.